-
Ovarian cancer: strategies for overcoming resistance to chemotherapy.
Nat Rev Cancer. 2003 Jul;3(7):502-16
PMID: 12835670
-
A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections.
J Immunol Methods. 2005 Apr;299(1-2):139-51
PMID: 15896802
-
HLA class I antigen loss, tumor immune escape and immune selection.
Vaccine. 2002 Dec 19;20 Suppl 4:A40-5
PMID: 12477427
-
Cancer vaccines: preclinical studies and novel strategies.
Adv Cancer Res. 2006;95:115-45
PMID: 16860657
-
HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story.
Mol Med Today. 1999 Apr;5(4):178-86
PMID: 10203751
-
Endoplasmic reticulum chaperone-specific monoclonal antibodies for flow cytometry and immunohistochemical staining.
Tissue Antigens. 2003 Nov;62(5):385-93
PMID: 14617045
-
Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
Clin Cancer Res. 2005 Apr 1;11(7):2552-60
PMID: 15814633
-
HLA class I antigen expression in malignant cells: why does it not always correlate with CTL-mediated lysis?
Curr Opin Immunol. 2004 Oct;16(5):644-50
PMID: 15342012
-
Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.
Clin Cancer Res. 2002 Oct;8(10):3193-7
PMID: 12374688
-
Tumour escape: antitumour effectors too much of a good thing?
Cancer Immunol Immunother. 2004 Mar;53(3):262-74
PMID: 14685780
-
Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.
Adv Immunol. 2000;74:181-273
PMID: 10605607
-
Role of antigen-processing machinery in the in vitro resistance of squamous cell carcinoma of the head and neck cells to recognition by CTL.
J Immunol. 2006 Mar 15;176(6):3402-9
PMID: 16517708
-
The structure of the T cell antigen receptor.
Annu Rev Immunol. 1996;14:563-90
PMID: 8717525
-
Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.
Clin Cancer Res. 2005 Dec 1;11(23):8304-11
PMID: 16322289
-
Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide.
J Immunol. 2003 Aug 15;171(4):1918-26
PMID: 12902494
-
12th International Histocompatibility Conference. Genetic diversity of HLA: functional and medical implications. Paris, France, June 9-12, 1996. Abstracts.
Hum Immunol. 1996 Apr 15-May;47(1-2):1-184
PMID: 8909580
-
Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation.
Clin Cancer Res. 2003 May;9(5):1721-7
PMID: 12738726
-
Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis.
J Immunol. 1999 Oct 15;163(8):4224-31
PMID: 10510359
-
HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.
Cancer Res. 2006 Sep 15;66(18):9281-9
PMID: 16982773
-
Study of tumor infiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinoma.
Int J Cancer. 1997 Oct 21;74(5):492-501
PMID: 9355970
-
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.
N Engl J Med. 2003 Jan 16;348(3):203-13
PMID: 12529460
-
Striking paucity of HLA-A, B, C and beta 2-microglobulin on human neuroblastoma cell lines.
J Immunol. 1983 May;130(5):2471-8
PMID: 6187860
-
Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications.
Oncogene. 2005 Jul 7;24(29):4634-44
PMID: 15897905
-
MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma.
Int J Cancer. 2004 Mar 20;109(2):265-73
PMID: 14750179
-
Cancer immunotherapy: a treatment for the masses.
Science. 2004 Jul 9;305(5681):200-5
PMID: 15247469
-
Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival?
Cancer Immunol Immunother. 2006 Aug;55(8):891-9
PMID: 16187081
-
HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage.
Clin Cancer Res. 2005 Jan 1;11(1):67-72
PMID: 15671529
-
Effector memory T cells, early metastasis, and survival in colorectal cancer.
N Engl J Med. 2005 Dec 22;353(25):2654-66
PMID: 16371631
-
Immunotherapy: bewitched, bothered, and bewildered no more.
Science. 2004 Jul 9;305(5681):197-200
PMID: 15247468
-
CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.
Cancer Res. 1998 Aug 15;58(16):3491-4
PMID: 9721846
-
Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products.
J Immunol. 1986 Oct 1;137(7):2299-306
PMID: 3760563
-
Molecular interactions between extracellular components of the T-cell receptor signaling complex.
Immunol Rev. 1999 Dec;172:73-85
PMID: 10631938
-
Mechanisms of MHC class I--restricted antigen processing.
Annu Rev Immunol. 1998;16:323-58
PMID: 9597133
-
Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression.
Am J Pathol. 1999 Mar;154(3):745-54
PMID: 10079252
-
Tumors as elusive targets of T-cell-based active immunotherapy.
Trends Immunol. 2003 Jun;24(6):335-42
PMID: 12810110
-
Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity.
Cancer Res. 2001 Jul 1;61(13):5132-6
PMID: 11431351